TY  - JOUR

T1  - JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy

JO  - Journal of Leukocyte Biology

UR  - http://eprints.whiterose.ac.uk/152772/

PY  - 2019/11/01

AU  - Gremese E

AU  - Alivernini S

AU  - Tolusso B

AU  - Zeidler MP

AU  - Ferraccioli G

ED  - 

DO  - DOI: 10.1002/jlb.5ru0519-145r

PB  - Wiley

VL  - 106

IS  - 5

SP  - 1063

EP  - 1068

Y2  - 2024/12/22

ER  -